跳至主要内容
临床试验/CTRI/2024/06/069220
CTRI/2024/06/069220招募中不适用

Implementation of inter-departmental collaborative medication review to reduce potentially inappropriate medication use in the hospitalized elderly patients: A mixed method study

Indian Council of Medical Research2 个研究点 分布在 1 个国家目标入组 280 人开始时间: 2024年8月12日最近更新:

试验速览

阶段
不适用
状态
招募中
入组人数
280
试验地点
2
主要终点
Facilitators and barriers in the implementation of inter-departmental Collaborative Medication Review to reduce potentially inappropriate medications

研究概览

简要总结

Rationale: The inappropriate use of multiple medications, known as polypharmacy, is a growing concern for the elderly population in India, who are often prescribed multiple medications due to comorbid conditions. This can lead to serious adverse health outcomes, increased healthcare costs, and reduced quality of life. Screening tools, such as Medication Appropriateness Index and START/STOPP criteria, can help identify potentially inappropriate medications (PIMs), and interventions, such as medication review clinics and prescribing audits, can help improve

|

appropriateness. Collaborative medication review involving a team approach is important to ensure that patients receive the best possible care. However, cost of these interventions remains a concern, especially in a country where healthcare spending is high for the elderly population.

Primary Objective: To assess the feasibility of implementation of inter-departmental Collaborative Medication Review (CMR) to reduce potentially inappropriate medications (PIMs) in the hospitalised elderly patients. Secondary Objectives:

a) To explore the facilitators and barriers in the implementation of inter-departmental CMR from the healthcare providers perspective b) To determine the costs involved in the implementation of inter-departmental CMR from health system perspective

c) To find out the efficacy of interdepartmental CMR using medication appropriateness index (MAI), post discharge adverse events and number of medication related admissions.

Methods: This study design will be a mixed method study, where the qualitative component will assess the feasibility of the collaborative medication review using in-depth interview and Focussed Group Discussion to explore the challenges in the implementation of interdepartmental collaborative medication review to reduce PIMs in the hospitalised elderly patients and the quantitative component of the study will estimate the costs incurred for the implementation of CMR in healthcare settings and reduction in the percentage of potentially inappropriate medications using START/STOPP criteria, medication appropriateness index (MAI) and post discharge adverse events. AT-HARM10 tool will be used to identify hospital admissions related to medications. A total of 280 hospitalised elderly participants’ prescriptions will be analysed in both the study sites from the admission day till 30 days post discharge by the CMR team members.

Expected Study outcomes:

• Facilitators and barriers in implementing CMR in different types of Indian healthcare setting

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
60.00 Year(s) 至 85.00 Year(s)(—)
性别
All

入选标准

  • All hospitalised elderly patients aged above 60 years.

排除标准

  • Those patients who will get discharged against medical advice before the completion of the treatment.
  • Patients who will be referred to other hospitals for varied reasons.
  • Those patients or patients’ kin who refuse to give consent to participate in the study.
  • Readmissions and emergency department visits other than DRPs.

结局指标

主要结局

Facilitators and barriers in the implementation of inter-departmental Collaborative Medication Review to reduce potentially inappropriate medications

时间窗: Medication charts will be reviewed every 3rd day since admission until discharge of the patient

次要结局

  • 1. Costs involved in the implementation of CMR in Indian healthcare settings (tertiary health care settings perspective)(2. Change in number of potentially inappropriate medications from hospital admission to discharge due to CMR.)

研究者

申办方类型
Government funding agency
责任方
Principal Investigator
主要研究者

Dr. Rajesh Kumar Konduru

Pondicherry Institute of Medical Sciences

研究点 (2)

Loading locations...

相似试验